Neurodevelopmental Drug Development Summit
December 14 - 15, 2021 - KS USHanson Wade
info@hansonwade.com
Phone:+442031418700
As investment in rare neurodevelopmental disorders is surging, there has never been a better time to unite all the key stakeholders across this fast-evolving community. The inaugural Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups paving the way towards symptomatic and successful disease modifying treatments. Developing new outcome measures that measure incremental change and target the neurodevelopmental disease itself, driving design innovation across disease-specific clinical trials, and capitalizing on the advances in new therapeutic modalities to drastically change the lives of patients in need. With increased understanding of genetic mechanisms sharpening our thoughts on targets and disease modifying approaches, we are now closer than ever to discovering treatments for the highest unmet need across neurodevelopmental disorders. If you are working towards treatments for rare neurodevelopmental disorders, including (but not limited to) Angelman Syndrome, Rett syndrome, Fragile X, Dravet Syndrome, or discovering new frontiers in anti-epileptic therapeutics, this is the platform you need.